LYZL2 Inhibitors
LYZL2 inhibitors belong to a class of chemical compounds designed to specifically target and modulate the activity of lysozyme-like protein 2 (LYZL2). Lysozymes are enzymes known for their ability to catalyze the hydrolysis of bacterial cell walls, contributing to the innate immune system's defense against microbial pathogens. LYZL2, a member of the lysozyme family, shares structural similarities with conventional lysozymes but exhibits distinct functional characteristics. The inhibitors developed for LYZL2 act as molecular entities that interfere with the protein's normal functioning, aiming to regulate its enzymatic activity or inhibit specific interactions within biological pathways.
Chemically, LYZL2 inhibitors are carefully designed compounds that interact with the active sites or binding pockets of LYZL2, impeding its catalytic function or disrupting its involvement in cellular processes. Ongoing research in this field focuses on refining the design and properties of LYZL2 inhibitors, paving the way for a deeper comprehension of their impact on cellular and molecular processes associated with the lysozyme family of proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ebselen | 60940-34-3 | sc-200740B sc-200740 sc-200740A | 1 mg 25 mg 100 mg | $33.00 $136.00 $458.00 | 5 | |
Ebselen is an organoselenium compound that mimics glutathione peroxidase, an enzyme that protects cells from oxidative damage. By acting as an antioxidant, Ebselen can indirectly affect the stability of LYZL2, as oxidative stress can modulate protein degradation pathways including lysosomal degradation, potentially leading to reduced levels of LYZL2. | ||||||
Allicin | 539-86-6 | sc-202449 sc-202449A | 1 mg 5 mg | $489.00 $1557.00 | 7 | |
Allicin is a compound derived from garlic with antimicrobial properties. It can react with thiol groups in proteins, which might lead to the modification of cysteine residues in LYZL2, potentially inhibiting its enzymatic activity. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram inhibits the enzyme aldehyde dehydrogenase. By altering aldehyde metabolism, it can lead to the accumulation of reactive aldehyde species that can form adducts with proteins. Such modifications could conceivably affect the function or stability of LYZL2. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that prevents the degradation of ubiquitinated proteins. By blocking the proteasomal degradation pathway, MG-132 could indirectly lead to the accumulation of proteins that compete with or negatively regulate LYZL2, thus inhibiting its functional activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is a natural compound from turmeric with anti-inflammatory and antioxidant properties. It modulates various signaling pathways, including the NF-κB pathway. By influencing this pathway, curcumin could alter the cellular environment in a way that indirectly decreases the functional activity of LYZL2. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a general inhibitor of protein tyrosine phosphatases. By inhibiting these phosphatases, it could conceivably affect tyrosine phosphorylation levels on proteins that interact with or regulate LYZL2, thereby modulating its activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, found naturally in soy products. It could alter phosphorylation cascades in the cell, possibly affecting proteins that modulate the stability or activity of LYZL2. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is an inhibitor of eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, thereby potentially decreasing the overall levels of LYZL2 by preventing its synthesis. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor. By inhibiting the proteasome, it can lead to the accumulation of misfolded or damaged proteins that could indirectly affect the function or stability of LYZL2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3), which is involved in numerous signaling pathways. Inhibition of GSK-3 could lead to altered signaling pathways that might indirectly reduce the functional activity of LYZL2. | ||||||